Legislative Services  |  Legislative Audits
Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels
facebook twitter
Facebook Twitter
Click to add bill to MyMGA list

SB0875

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Public Health – Medetomidine and Xylazine Consumer Protection Act
Sponsored by
Senator Folden
Status
In the Senate - First Reading Finance
Analysis
Synopsis
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product unless the purchaser provides to the retailer certain proof; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine product or a xylazine product to maintain certain records; etc.
Committees
Original:
Finance
Details
Cross-filed with: HB1109
Bill File Type: Regular
Effective Date(s): October 1, 2025
History
Legislation History
Chamber
Senate
Calendar Date
2/03/2025
Legislative Date
1/28/2025
Action
First Reading Finance
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Public Health – Medetomidine and Xylazine Consumer Protection Act
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 2/03/2025 1/28/2025 First Reading Finance
Text - First - Public Health – Medetomidine and Xylazine Consumer Protection Act
File Code
Subjects
Statutes
Article - Health - General
(   21-2F-01 through 21-2F-03, 8-6A-01   )
Last Updated: 2/5/2025 11:09 AM
Click to return on the top page